Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The main purpose of this study is to assess the immunogenicity and safety of the concomitant and sequential administration of yellow fever (YF) vaccine and tetravalent dengue vaccine (TDV) in healthy participants aged 18 to 60 years living in country non-endemic for both dengue and YF.
Epistemonikos ID: c0f78a00d93622e7f2c845eb8791d6d69f041353
First added on: May 21, 2024